- Home
- PRZO vs CASI Comparison
PRZO vs CASI Comparison
Compare PRZO & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRZO
- CASI
- Stock Information
- Founded
- PRZO 2014
- CASI 1991
- Country
- PRZO Israel
- CASI China
- Employees
- PRZO N/A
- CASI N/A
- Industry
- PRZO
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- PRZO
- CASI Health Care
- Exchange
- PRZO Nasdaq
- CASI Nasdaq
- Market Cap
- PRZO 20.1M
- CASI 20.5M
- IPO Year
- PRZO 2023
- CASI 1996
- Fundamental
- Price
- PRZO $1.61
- CASI $1.40
- Analyst Decision
- PRZO
- CASI Strong Buy
- Analyst Count
- PRZO 0
- CASI 1
- Target Price
- PRZO N/A
- CASI $4.00
- AVG Volume (30 Days)
- PRZO 2.1M
- CASI 313.5K
- Earning Date
- PRZO 09-02-2025
- CASI 08-15-2025
- Dividend Yield
- PRZO N/A
- CASI N/A
- EPS Growth
- PRZO N/A
- CASI N/A
- EPS
- PRZO N/A
- CASI N/A
- Revenue
- PRZO $932,154.00
- CASI $31,368,000.00
- Revenue This Year
- PRZO N/A
- CASI N/A
- Revenue Next Year
- PRZO N/A
- CASI N/A
- P/E Ratio
- PRZO N/A
- CASI N/A
- Revenue Growth
- PRZO 50.22
- CASI 8.39
- 52 Week Low
- PRZO $0.49
- CASI $1.09
- 52 Week High
- PRZO $3.16
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- PRZO 67.69
- CASI 44.81
- Support Level
- PRZO $1.37
- CASI $1.23
- Resistance Level
- PRZO $1.52
- CASI $1.50
- Average True Range (ATR)
- PRZO 0.10
- CASI 0.12
- MACD
- PRZO 0.03
- CASI 0.03
- Stochastic Oscillator
- PRZO 74.06
- CASI 78.05
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the company applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.